The Latest Analyst Ratings for Chemours
Portfolio Pulse from Benzinga Insights
Analysts have provided various ratings for Chemours (NYSE:CC) within the last quarter, with 1 bullish, 1 somewhat bullish, and 6 indifferent. The average price target is $40.5, implying an upside from the current price of $36.39. This average price target has increased by 2.84% over the past month.
July 31, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts' ratings for Chemours are mostly indifferent with a few bullish. The average price target suggests an upside potential.
The majority of analysts are indifferent about Chemours, indicating uncertainty about the company's future performance. However, the average price target, which is higher than the current price, suggests that there is potential for the stock price to increase. This could have a positive impact on the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100